367 related articles for article (PubMed ID: 22173163)
1. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis.
Kisseleva T; Brenner DA
J Hepatol; 2012 Apr; 56(4):965-72. PubMed ID: 22173163
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived fibrocytes contribute to liver fibrosis.
Xu J; Kisseleva T
Exp Biol Med (Maywood); 2015 Jun; 240(6):691-700. PubMed ID: 25966982
[TBL] [Abstract][Full Text] [Related]
3. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis.
Li C; Kong Y; Wang H; Wang S; Yu H; Liu X; Yang L; Jiang X; Li L; Li L
J Hepatol; 2009 Jun; 50(6):1174-83. PubMed ID: 19398237
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
5. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.
Xu J; Liu X; Koyama Y; Wang P; Lan T; Kim IG; Kim IH; Ma HY; Kisseleva T
Front Pharmacol; 2014; 5():167. PubMed ID: 25100997
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.
Kisseleva T; Uchinami H; Feirt N; Quintana-Bustamante O; Segovia JC; Schwabe RF; Brenner DA
J Hepatol; 2006 Sep; 45(3):429-38. PubMed ID: 16846660
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis.
Yang L; Chang N; Liu X; Han Z; Zhu T; Li C; Yang L; Li L
Am J Pathol; 2012 Jul; 181(1):85-97. PubMed ID: 22609227
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular mechanisms of liver fibrosis and its regression.
Kisseleva T; Brenner D
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes.
Luo XY; Meng XJ; Cao DC; Wang W; Zhou K; Li L; Guo M; Wang P
Stem Cell Res Ther; 2019 Jan; 10(1):16. PubMed ID: 30635047
[TBL] [Abstract][Full Text] [Related]
10. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.
Roderfeld M; Rath T; Voswinckel R; Dierkes C; Dietrich H; Zahner D; Graf J; Roeb E
Hepatology; 2010 Jan; 51(1):267-76. PubMed ID: 19827165
[TBL] [Abstract][Full Text] [Related]
12. The bone marrow functionally contributes to liver fibrosis.
Russo FP; Alison MR; Bigger BW; Amofah E; Florou A; Amin F; Bou-Gharios G; Jeffery R; Iredale JP; Forbes SJ
Gastroenterology; 2006 May; 130(6):1807-21. PubMed ID: 16697743
[TBL] [Abstract][Full Text] [Related]
13. The Origin and Fate of Liver Myofibroblasts.
Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T
Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived cells contribute to cerulein-induced pancreatic fibrosis in the mouse.
Lin WR; Inatomi O; Lee CY; Kallis YN; Otto WR; Jeffery R; Poulsom R; Alison MR
Int J Exp Pathol; 2012 Apr; 93(2):130-8. PubMed ID: 22283686
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome Proliferator-Activated Receptor Gamma Negatively Regulates the Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Toward Myofibroblasts in Liver Fibrogenesis.
Jia S; Liu X; Li W; Xie J; Yang L; Li L
Cell Physiol Biochem; 2015; 37(6):2085-100. PubMed ID: 26599535
[TBL] [Abstract][Full Text] [Related]
16. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
[TBL] [Abstract][Full Text] [Related]
17. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
[TBL] [Abstract][Full Text] [Related]
18. Migration of fibrocytes in fibrogenic liver injury.
Scholten D; Reichart D; Paik YH; Lindert J; Bhattacharya J; Glass CK; Brenner DA; Kisseleva T
Am J Pathol; 2011 Jul; 179(1):189-98. PubMed ID: 21703401
[TBL] [Abstract][Full Text] [Related]
19. Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway.
Bi H; Ming L; Cheng R; Luo H; Zhang Y; Jin Y
J Tissue Eng Regen Med; 2017 Oct; 11(10):2685-2698. PubMed ID: 27430962
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
Higashiyama R; Inagaki Y; Hong YY; Kushida M; Nakao S; Niioka M; Watanabe T; Okano H; Matsuzaki Y; Shiota G; Okazaki I
Hepatology; 2007 Jan; 45(1):213-22. PubMed ID: 17187438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
